Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer

THURSDAY, March 28, 2024 -- Patients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their postsurgery chemotherapy treatment, according to a study presented at the annual European Breast Cancer Conference,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news